Safety of myocardial flash-contrast echocardiography in combination with dobutamine stress testing for the detection of ischaemia in 5250 studies

Heart

Volumn 94, Issue 12, 2008, Pages 1571-1577

  Aggeli, C ^a,b   Giannopoulos, G ^a   Roussakis, G ^a   Christoforatou, E ^a   Marinos, G ^a   Toli, C ^a   Pitsavos, C ^a   Stefanadis, C ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; DOBUTAMINE;

ADULT; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; FEMALE; HEADACHE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; HYPERSENSITIVITY REACTION; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT SAFETY; PRIORITY JOURNAL; RESUSCITATION; SENSITIVITY AND SPECIFICITY; STRESS ECHOCARDIOGRAPHY; SUPRAVENTRICULAR TACHYCARDIA; SYSTOLIC BLOOD PRESSURE;

CONTRAST MEDIA; DOBUTAMINE; ECHOCARDIOGRAPHY; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PHOSPHOLIPIDS; SENSITIVITY AND SPECIFICITY; SULFUR HEXAFLUORIDE;

EID: 54949156274     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2007.135145     Document Type: Article

References (39)

1. Beleslin BD, Ostojic M, Stepanovic J, et al. Stress echocardiography in the detection of myocardial ischemia. Head-to-head comparison of exercise, dobutamine, and dipyridamole tests. Circulation 1994;90:1168-76.
2. Dagianti A, Penco M, Agati L, et al. Stress echocardiography: comparison of exercise, dipyridamole and dobutamine in detecting and predicting the extent of coronary artery disease. J Am Coll Cardiol 1995;26:18-25.
3. Okajima K, Kawase Y, Matsushita N, et al. Usefulness of myocardial contrast echocardiography with nicorandil stress for the detection of coronary artery stenosis. Heart 2006;92:1331-2.
4. Picano E, Mathias W Jr, Pingitore A, et al. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Echo Dobutamine International Cooperative Study Group. Lancet 1994;344:1190-2.
5. Mathias W Jr, Arruda A, Santos FC, et al. Safety of dobutamine-atropine stress echocardiography: a prospective experience of 4,033 consecutive studies. J Am Soc Echocardiogr 1999;12:785-91.
6. Elhendy A, van Domburg RT, Poldermans D, et al. Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test. Diabetes Care 1998;21:1797-802.
7. Senior R, Andersson O, Caidaht K, et al. Enhanced left ventricular delineation with an intravenous injection of SonoVue, a new echocardiographic contrast agent: a European multicentre clinical trial. Echocardioraphy 2000;17:705-11.
8. Porter TR, Xie F, Kricsfeld A, et al. Improved endocardial border resolution during dobutamine stress echocardiography with intravenous sonicated dextrose albumin. J Am Coll Cardiol 1994;23:1440-3.
9. Soliman O, Knaapen P, Geleijnse M, et al. Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography. Heart 2007;93:1204-12.
10. Moir S, Hanekom L, Fang Z-Y, et al. Relationship between myocardial perfusion and dysfunction in diabetic cardiomyopathy: a study of quantitative contrast echocardiography and strain rate imaging. Heart 2006;92:1414-19.
11. Shimoni S, Zoghbi WA, Xie F, et al. Real-time assessment of myocardial perfusion and wall motion during bicycle and treadmill exercise echocardiography: comparison with single photon emission computed tomography. J Am Coll Cardiol 2001;37:741-7.
12. Elhendy A, O'Leary EL, Xie F, et al. Comparative accuracy of real-time myocardial contrast perfusion imaging and wall motion analysis during dobutamine stress echocardiography for the diagnosis of coronary artery disease. J Am Coll Cardiol 2004;44:2185-91.
13. Moir S, Haluska BA, Jenkins C, et al. Incremental benefit of myocardial contrast to combined dipyridamole-exercise stress echocardiography for the assessment of coronary artery disease. Circulation 2004;110:1108-13.
14. Ay T, Havaux X, Van Camp G, et al. Destruction of contrast microbubbles by ultrasound effects on myocardial function, coronary perfusion pressure, and microvascular integrity. Circulation 2001;104:461-6.
15. van Der Wouw PA, Brauns AC, Bailey SE, et al. Premature ventricular contractions during triggered imaging with ultrasound contrast. J Am Soc Echocardiogr 2000;13:288-94.
16. Timperley J, Mitchell ARJ, Thibault H, et al. Safety of contrast dobutamine stress echocardiography: a single center experience. J Am Soc Echocardiogr 2005;18:163-7.
17. Tsutsui JM, Elhendy A, Xie F, et al. Safety of dobutamine stress real-time myocardial contrast echocardiography. J Am Coll Cardiol 2005;45:1235-42.
18. Lu D, Greenberg MD, Little R, et al. Accelerated dobutamine stress testing: safety and feasibility in patients with known or suspected coronary artery disease. Clin Cardiol 2001;24:141-5.
19. Burger AJ, Notarianni MP, Aronson D. Safety and efficacy of an accelerated dobutamine stress echocardiography protocol in the evaluation of coronary artery disease. Am J Cardiol 2000;86:825-9.
20. Lepper W, Belcik T, Wei K, et al. Myocardial contrast echocardiography. Circulation 2004;109:3132-5.
21. Senior R, Lepper W, Pasquet A, et al. Myocardial perfusion assessment in patients with medium probability of coronary artery disease and no prior myocardial infarction: comparison of myocardial contrast echocardiography with 99mTc single-photon emission computed tomography. Am Heart J 2004;147:1100-5.
22. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-42.
23. Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003;13:176-81.
24. Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events, version 3.0. DCTD, NCI, NIH, DHHS. 9 August 2006. http://ctep.cancer.gov/forms/CTCAEv3.pdf (accessed June 2008).
25. von Bibra H, Sutherland G, Becher H, et al. Clinical evaluation of left heart Doppler contrast enhancement by a saccharide-based transpulmonary contrast agent. The Levovist Cardiac Working Group. J Am Coll Cardiol 1995;25:500-8.
26. Aggeli CJ, Shimoni S, Nagueh SF, et al. Quantitative parameters of myocardial perfusion with contrast echocardiography in human beings: influence of triggering mode. J Am Soc Echocardiogr 2002;15:1432-9.
27. Aggeli C, Stefanadis C, Bonou M, et al. Prediction of functional recovery of hibernating myocardium using harmonic power Doppler imaging and dobutamine stress echocardiography in patients with coronary artery disease. Am J Cardiol 2003;91:1415-20.
28. Secknus MA, Marwick TH. Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3,011 studies over 5 years. J Am Coll Cardiol 1997;29:1234-40.
29. Senior R, Lepper W, Pasquet A, et al. Myocardial perfusion assessment in patients with medium probability of coronary artery disease and no prior myocardial infarction: comparison of myocardial contrast echocardiography with 99mTc single-photon emission computed tomography. Am Heart J 2004;147:1100-5.
30. Jeetley P, Hickman M, Kamp O, et al. Myocardial contrast echocardiography for the detection of coronary artery stenosis: a prospective multicenter study in comparison with single-photon emission computed tomography. J Am Coll Cardiol 2006;47:141-5.
31. Dijkmans PA, Senior R, Becher H, et al. Myocardial contrast echocardiography evolving as a clinically feasible technique for accurate, rapid, and safe assessment of myocardial perfusion: the evidence so far. J Am Coll Cardiol 2006;48:2168-77.
32. Aggeli C, Bonou M, Stefanadis C. Potential clinical applications of myocardial contrast echocardiography in evaluating myocardial perfusion in coronary artery disease. Int J Cardiol 2005;104:1-9.
33. Shimoni S, Frangogiannis NG, Aggeli CJ, et al. Microvascular structural correlates of myocardial contrast echocardiography in patients with coronary artery disease and left ventricular dysfunction: implications for the assessment of myocardial hibernation. Circulation 2002;106:950-6.
34. Palanchon P, Tortoli P, Bouakaz A, et al. Optical observations of acoustical radiation force effects on individual air bubbles. IEEE Trans Ultrason Ferroelectr Freq Control 2005;52:104-10.
35. Rota C, Raeman CH, Child SZ, et al. Detection of acoustic cavitation in the heart with microbubble contrast agents in vivo: a mechanism for ultrasound-induced arrhythmias. J Acoust Soc Am 2006;120:2958- 64.
36. Vancraeynest D, Kefer J, Hanet C, et al. Release of cardiac bio-markers during high mechanical index contrast-enhanced echocardiography in humans. Eur Heart J 2007;28:1236-41.
37. Borges AC, Walde T, Reibis RK, et al. Does contrast echocardiography with Optison induce myocardial necrosis in humans? J Am Soc Echocardiogr 2002;15:1080-6.
38. Gary MM, Harrison DJ. Analysis of severe adverse events related to the use of mifepristone as an abortifacient. Ann Pharmacother 2006;40:191-7.
39. Zane LT, Leyden WA, Marqueling AL, et al. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris. Arch Dermatol 2006;142:1016-22.